Incyte Medical shares surged by 5.2% after the company announced that its skin disease treatment drug Opzelura received a positive opinion from EU regulators.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This positive news has boosted market confidence, highlighting the key regulatory progress of this therapy's commercialization in the European market.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Houlihan Lokey completes acquisition of Intrepid Financial Partners
Reuters•2026/09/14 13:54
Newrez survey: 51% of US homeowners carry credit card debt month-to-month
Reuters•2026/09/14 13:53
Sanofi to Acquire 26.4% Stake in Cheplapharm
MT newswire•2026/09/14 13:52
Crypto prices
MoreBitcoin
BTC
$78,267.9
+1.82%
Ethereum
ETH
$2,504.45
+1.08%
Tether USDt
USDT
$0.9996
-0.01%
BNB
BNB
$720.41
+0.68%
XRP
XRP
$1.4
+4.26%
USDC
USDC
$0.9998
-0.00%
Solana
SOL
$101.55
+1.49%
TRON
TRX
$0.3409
+0.04%
Hyperliquid
HYPE
$80.47
+3.08%
Zcash
ZEC
$1,145.08
+4.50%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now